- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/6527 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
Patent holdings for IPC class C07F 9/6527
Total number of patents in this class: 11
10-year publication summary
|
0
|
1
|
3
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cancer Targeted Technology LLC | 28 |
5 |
| Eisai R&D Management Co., Ltd. | 1225 |
2 |
| Haisco Pharmaceuticals Pte. Ltd. | 14 |
2 |
| Mitsubishi Tanabe Pharma Corporation | 582 |
1 |
| Centre National de La Recherche Scientifique (cnrs) | 3103 |
1 |
| Other owners | 0 |